RFLP£¨Restriction Fragment Length Polymorphism, RFLP£©ÏÞÖÆÐÔÆ¬¶Î³¤¶È¶à̬ÐÔ£¬µ±ÓÃÏÞÖÆÐÔÄÚÇÐøÇиͬƷÖÖ»ò¸öÌåµÄ»ùÒò×éDNAʱ£¬Èç¹ûÏÞÖÆÐÔÄÚÇÐøµÄøÇÐλµãµÄ¼î»ù·¢ÉúÍ»±ä£¬»òÕßøÇÐλµãÖ®¼äDNAƬ¶Î·¢Éú¼î»ùµÄ²åÈë»òȱʧ£¬µ¼ÖÂøÇÐÆ¬¶ÏµÄ´óС¡¢ÊýÁ¿·¢ÉúÁ˱仯£¬²úÉúÏ൱¶àµÄÊýÄ¿ºÍ´óС²»µÈµÄDNAƬ¶Î¡£ÕâÖֱ仯¿ÉÒÔͨ¹ýÌØ¶¨µÄ̽ÕëÔÓ½»½øÐмì²â£¬´Ó¶ø¿ÉÒԱȽϲ»Í¬Æ·ÖÖ»ò¸öÌåÖ®¼äµÄDNAˮƽµÄ²îÒ죨»ò¶à̬ÐÔ£©¡£¹ã·ºÓÃÓÚ»ùÒò×éÒÅ´«Í¼Æ×¹¹½¨¡¢»ùÒò¶¨Î»ÒÔ¼°ÉúÎïµÄ½ø»¯ºÍ·ÖÀà¹ØÏµÑо¿¡£ Y{{,62D
!aoO,P#j
RAPD£¨Random Amplified Polymorphism DNA, RAPD£©Ëæ»úÀ©Ôö¶à̬ÐÔDNA£¬ÀûÓÃËæ¼´ÒýÎïÀ©ÔöѰÕÒ¶à̬ÐÔDNAƬ¶ÎµÄ·Ö×Ó±ê¼Ç·½·¨¡£Êǽ¨Á¢ÔÚPCR¼¼Êõ»ù´¡ÉÏ£¬ÀûÓÃһϵÁУ¨Í¨³£Êý°Ù£©²»Í¬µÄËæ»úÅÅÁмî»ù˳ÐòµÄ¹Ñ¾ÛºËÜÕËáµ¥Á´£¨Ò»°ãΪ10 bp£©ÎªÒýÎ¶ÔËùÑо¿µÄ»ùÒò×éDNA½øÐÐPCRÀ©Ôö£¬È»ºóÓÃÄý½ºµçÓ¾·Ö¿ªÀ©ÔöƬ¶Î£¬EBµÈȾɫ¼ÁȾɫºó¼ì²âÀ©Ôö²úÎïDNAƬ¶ÎµÄ¶à̬ÐÔ¡£ÓëRAPD¼¼ÊõÏàÀàËÆµÄ»¹ÓÐAP-PCR£¨Arbitrary Primed PCR£©ºÍDAF£¨DNA Amplified Fingerprints£©2ÖÖ±ê¼Ç¼¼Êõ¡£ÔÚAP-PCR·ÖÎöÖУ¬ËùʹÓõÄÒýÎï½Ï³¤£¨Í¨³£10¡«50 bp£©£¬À©Ôö·ÖΪ3¸ö²¿·Ö£¬Ã¿¸ö²¿·ÖÒªÇóµÄÌõ¼þºÍ×é·ÖµÄŨ¶È´æÔÚ²îÒì¡£DAFÊÇÒ»ÖָĽøµÄRAPD·ÖÎö¼¼Êõ£¬ÓëRAPD¼¼Êõ²»Í¬µÄÊÇËüʹÓÃÒýÎïŨ¶È¸ü¸ß£¬³¤¶È¸ü¶Ì£¨Ò»°ã5¡«8 bp£©£¬Ö»ÓÐ2¸öζÈÑ»·£¬²¢³£Óþ۱ûÏ©õ£°·Äý½ºµçÓ¾£¬ËùÌṩÆ×´øÐÅÏ¢±ÈRAPD´óµÃ¶à¡£ }E_zW.{!
t)b>f~
AFLP£¨Amplified fragment length polymorphism£¬AFLP£© À©ÔöƬ¶Î³¤¶È¶à̬ÐÔ£¬AFLPÊÇRFLPºÍPCR½áºÏµÄ²úÎÆä»ù±¾ÔÀíÊÇ£º½«»ùÒò×éDNA½øÐÐÏÞÖÆÐÔÄÚÇÐøøÇУ¬È»ºóÑ¡ÔñÌØ¶¨µÄƬ¶Î½øÐÐPCRÀ©Ôö£¬Ê¹ÓÃË«Á´È˹¤"½ÓÍ·"Óë»ùÒò×éDNAµÄøÇÐÆ¬¶ÎÏàÁ¬½Ó×÷ΪÀ©Ôö·´Ó¦Ä£°å£¬"½ÓÍ·"Óë"½ÓÍ·"ÏàÁ򵀿ÇÐÆ¬¶ÎµÄ¼¸¸ö¼î»ùÐòÁÐ×÷ΪÒýÎïµÄ½áºÏλµã¡£ÕâÑù¾ÍÖ»ÓÐÄÇЩÁ½¶ËÐòÁÐÄÜÓëÑ¡Ôñ¼î»ùÅä¶ÔµÄÏÞÖÆÐÔÆ¬¶Î±»À©Ôö£¬ÔÙÔڸ߷ֱæÁ¦µÄ²âÐò½ºÉÏ·Ö¿ªÕâЩÀ©Ôö²úÎï¡£¸Ã¼¼ÊõµÄ¶ÀÌØÖ®´¦ÔÚÓÚËùÓõÄרÓÃÒýÎï¿ÉÔÚ²»ÖªµÀDNAÐÅÏ¢µÄǰÌáϾͿɶÔøÇÐÆ¬¶Î½øÐÐPCRÀ©Ôö¡£ÊÇĿǰһÖÖÊ®·ÖÀíÏëÓÐЧµÄ·Ö×Ó±ê¼Ç ,FP
gs0rrS
p`C5jfI
STS£¨Sequence-Tagged Site, STS£©ÐòÁбêǩλµã ÊÇ»ùÒò×éÉ϶¨Î»Ã÷È·¡¢×÷Ϊ½ç±ê²¢ÄÜͨ¹ýPCRÀ©Ôö±»Î¨Ò»²Ù×÷µÄ¶ÌµÄ¡¢µ¥¿½±´DNA ÐòÁУ¬£¬ÓÃÓÚ²úÉú×÷ͼλµã£¬¼´²â¶¨Ò»ÏµÁÐSTS µÄ´ÎÐò¼´¿É×÷³ö»ùÒò×éÇøÓòµÄͼÆ×¡£STSÖ÷Òª°üÀ¨¼òµ¥Öظ´ÐòÁУ¨Simple Sequence Repeat Polymorphisms, ¼ò³ÆSSR»òSSRP£©¡¢Ãª¶¨¼òµ¥Öظ´ÐòÁУ¨ Anchored Simple Sequence Repeats, ASSR£©¡¢ÐòÁÐÌØÒìÀ©ÔöÇøÓò£¨Sequence-characterized amplified regions£©¡¢Ã¸ÇÐÀ©Ôö¶à̬ÐÔÐòÁУ¨Cleaved Amplified Polymorphism Sequences, CAPS£©¡¢µ¥ÒýÎïÀ©Ôö·´Ó¦£¨Single Primer Amplification Reaction, SPAR£©µÈ±ê¼Ç¼¼Êõ¡£ ~_6rD`2cJ
PSvRO%&
SSR (Simple¡¡Sequence¡¡Repeats£¬SSR) ¼òµ¥Öظ´ÐòÁÐ ÕæºËÉúÎïµÄ»ùÒò×éÖÐÉ¢²¼´óÁ¿µÄ´®ÁªÖظ´ÐòÁУ¬ÆäÖÐ2¡«4¸öbpµÄ΢ÎÀÐÇÐòÁоßÓи߶ȶà̬ÐÔ£¬Î¢ÎÀÐÇÔڽṹÉϵÄ×î´óÌØµãÊÇÁ½¶ËÐòÁнϱ£ÊØ£¬Òò´Ë¿ÉÉè¼ÆÓëÁ½¶Ë±£ÊØÐòÁл¥²¹µÄÒýÎï½øÐÐPCEÀ©Ôö£¬À´½Òʾ΢ÎÀÐǵĶà̬ÐÔ¡£SSR ÊǼì²â¶à̬ÐÔµÄÒ»ÖÖÓÐЧ·½·¨¡£ ,peFNpi
LDNUywj@w
SSCP£¨Single Strand Conformation Polymorphism, SSCP£©µ¥Á´¹¹Ïñ¶à̬ÐÔ ÊÇÖ¸Ïàͬ³¤¶ÈµÄµ¥Á´DNAÒòºËÜÕËáÐòÁеIJîÒ죬ÉõÖÁµ¥¸ö¼î»ù²»Í¬£¬¶ø²úÉúµÄ¹¹Ïñ±äÒ죬ÔڷDZäÐÔ¾Û±ûÏ©õ£°·ÖбíÏÖΪµçÓ¾Ç¨ÒÆÂʵIJî±ð¡£PCR²úÎï±äÐÔ´¦Àí£¬Ë«Á´DNA·Ö¿ª³Éµ¥Á´£¬ÔÙÓ÷DZäÐÔ¾Û±ûÏ©õ£°·Äý½ºµçÓ¾·ÖÀ룬¸ù¾ÝÌõ´øÎ»Öñ仯À´ÅжÏÄ¿µÄƬ¶ÎÖÐÊÇ·ñ´æÔÚÍ»±ä¡£SSCP·ÖÎö¶ÔDNAÐòÁеĸıä·Ç³£Ãô¸Ð£¬³£³£Ò»¸ö¼î»ù²î±ð¶¼ÄÜÏÔʾ³öÀ´¡£SSCP½á¹ûÅж¨ÊÇͨ¹ý¶à¸öÑùÆ·Ö®¼ä¶Ô±È£¬¹Û²ìÌõ´øÖ®¼äλÖøı䣬´Ó¶øÏÔʾ³ö²»Í¬ÉúÎï¸öÌåµÄDNAÌØÒìÐÔ£¬´ïµ½Ö¸ÎÆ·ÖÎöµÄÄ¿µÄ¡£¸Ã¼¼ÊõÒѱ»¹ã·ºÓÃÓÚ°©»ùÒòºÍ¿¹°©»ùÒò±äÒìµÄ¼ì²â¡¢ÒÅ´«²¡µÄÖ²¡»ùÒò·ÖÎöÒÔ¼°»ùÒòÕï¶Ï¡¢»ùÒòÖÆÍ¼µÈÁìÓò¡£ e=C,`&sz
z oXF"Nz
SNP£¨Single Nucleotide Polymorphism, SNP£©µ¥ºËÜÕËá¶à̬ÐÔ ÊÇÖ¸DNAÐòÁÐÉϵ¥¸öºËÜÕËáµÄ²îÒ죬Êǵ¥¸öºËÜÕËáÖû»²úÉúµÄÒÅ´«±ê¼Ç¡£¸ù¾Ý´ÓSTSÖÐÈ·¶¨SNPλµãµÄ¾Ñ飬ÿǧ¸öºËÜÕËá»á³öÏÖÒ»¸ö±ê¼Çλµã£¬ÒòSNPµÄ·Ö²¼Ãܼ¯¡£¼ì²âSNPµÄ×î¼Ñ·½·¨ÊÇDNAоƬ¼¼Êõ£¬Èç¹ûÄܽ«ËùÓÐSNPÈ«²¿ÐÅÏ¢ÔØÈëDNAоƬ£¬¾Í¿ÉÖÆÔì»ùÒò×éɨÃèÒÇ£¬ÓÃÀ´É¨Ãè¸÷¸ö¸öÌå²¢·ÖÎöËüÃÇÔÚ»ùÒò×é³ÉÉϵIJîÒì¡£ iWsIc\!+,
DenCD9 f
SCAR(Sequence-characterized amplified regions) SCAR±ê¼ÇÊÇÔÚRAPD¼¼ÊõµÄ»ù´¡ÉÏ·¢Õ¹ÆðÀ´µÄ¡£Ä¿±êRAPDƬ¶Î¿Ë¡ºÍ²âÐò£¬¸ù¾ÝÔRAPDƬ¶ÎÁ½Ä©¶ËµÄÐòÁÐÉè¼ÆÌØ¶¨ÒýÎï½øÐÐPCRÌØÒìÀ©Ôö¡£ =Ih_[$1dw
dDTt _B
EST£¨expressed sequence tag£¬EST£©±í´ïÐòÁбêÇ© ¶ÌµÄ¡¢µ¥´Î£¨²âÐò£©ÔĶÁµÄcDNA 5¡¯»ò3¡®¶ËÐòÁС£Ò²°üÀ¨À´×ÔÓÚ²îÒìÏÔʾºÍRACEʵÑéµÄcDNAÐòÁС£Ò»°ãÊÇÀ´×Ô²»Í¬×éÖ¯À´Ô´µÄcDNAÐòÁУ¬³¤¶ÈÔÚ300-500bp×óÓÒ¡£ l$NEx0Dffz
Z$gY}Bz
Contig ÖØµþȺ»òÁÚ½ÓÆ¬¶Î »ùÒò×é²âÐòÖн«Ðí¶àÐòÁÐÆ¬¶Î¾¹ý±È¶ÔÕÒµ½ÖصþÇø£¬´Ó¶øÁ¬½Ó³É³¤Æ¬¶Î£¬ÕâЩƬ¶Ï³ÆÖصþÁ¬ÐøÈº£¬¼ò³ÆÖصþȺ¡£ pwQ."2x
pgarGaeq
UniGene ¡ª ±»ÕûÀí³É´ØµÄESTºÍÈ«³¤mRNAÐòÁУ¬Ã¿Ò»¸ö´ú±íÒ»ÖÖÌØ¶¨ÒÑÖªµÄ»ò¼ÙÉèµÄÈËÀà»ùÒò£¬Óж¨Î»Í¼ºÍ±í´ïÐÅÏ¢ÒÔ¼°Í¬ÆäËü×ÊÔ´µÄ½»²æ²Î¿¼¡£ uhL
W/?q.
EJsb{$u
SAGE£¨serial analysis of gene expression,£©£¬»ùÒò±í´ïϵÁзÖÎö Êǽü¼¸ÄêÀ´·¢Õ¹ÆðÀ´µÄÒ»ÖÖ¿ìËÙ·ÖÎö»ùÒò±í´ïˮƽÐÅÏ¢µÄ¼¼Êõ¡£Ëüͨ¹ý¿ìËÙºÍÏêϸ·ÖÎö³ÉǧÉÏÍò¸öESTÀ´Ñ°ÕÒ³ö±í´ï·á¶È²»Í¬µÄSAGE±êÇ©ÐòÁУ¬´Ó¶ø½Ó½üÍêÕûµØ»ñµÃ»ùÒò×éµÄ±í´ïÐÅÏ¢¡£ _7VU ,
gfHlY Q]
»ùÒò×éѧ£*****enomics£©£¬Ö¸¶ÔËùÓлùÒò½øÐлùÒò×é×÷ͼ£¨°üÀ¨ÒÅ´«Í¼Æ×¡¢ÎïÀíͼÆ×¡¢×ªÂ¼±¾Í¼Æ×£©£¬ºËÜÕËáÐòÁзÖÎö£¬»ùÒò¶¨Î»ºÍ»ùÒò¹¦ÄÜ·ÖÎöµÄÒ»ÃÅ¿ÆÑ§¡£»ùÒò×éÑо¿Ó¦¸Ã°üÀ¨Á½·½ÃæµÄÄÚÈÝ£ºÒÔÈ«»ùÒò×é²âÐòΪĿ±êµÄ½á¹¹»ùÒò×éѧºÍÒÔ»ùÒò¹¦Äܼø¶¨ÎªÄ¿±êµÄ¹¦ÄÜ»ùÒò×éѧ£¬ÓÖ±»³ÆÎªºó»ùÒò×飨postgenome£©Ñо¿¡£ TW$^]u~v
{0~ p" %*
µ°°×ÖÊ×飨proteome£©Ö¸È«²¿»ùÒò±í´ïµÄÈ«²¿µ°°×Öʼ°Æä´æÔÚ·½Ê½£¬ÊÇÒ»¸ö»ùÒò¡¢Ò»¸öϸ°û»ò×éÖ¯Ëù±í´ïµÄÈ«²¿µ°°×Öʳɷ֣¬µ°°×ÖÊ×éѧÊDz»Í¬Ê±¼äºÍ¿Õ¼ä·¢»Ó¹¦ÄܵÄÌØ¶¨µ°°×ÖÊȺÌåµÄÑо¿¡£ 6I<`N
s4\2lBU?
µ°°×ÖÊ×éѧ£¨protemics£©¡£µ°°×ÖÊ×éѧÊDz»Í¬Ê±¼äºÍ¿Õ¼ä·¢»Ó¹¦ÄܵÄÌØ¶¨µ°°×ÖÊȺÌåµÄÑо¿¡£Ëü´Óµ°°×ÖÊˮƽÉÏ̽Ë÷µ°°×ÖÊ×÷ÓÃģʽ£¬¹¦ÄÜ»úÀí¡¢µ÷½Ú¿ØÖÆ¡¢Ò©Î↑·¢¡¢Ð³´úл;¾¶µÈÌṩÀíÂÛÒÀ¾ÝºÍ»ù´¡¡£ +yk>jx
B:SRHd{*Wu
¹¦ÄÜ»ùÒò×éѧ£¨Functuional¡¡genomics£©ÓÖ³ÆÎªºó»ùÒò×éѧ£¨Postgenomics£©£¬ËüÀûÓýṹ»ùÒò×éËùÌṩµÄÐÅÏ¢ºÍ²úÎ·¢Õ¹ºÍÓ¦ÓÃеÄʵÑéÊֶΣ¬Í¨¹ýÔÚ»ùÒò×é»òϵͳˮƽÉÏÈ«Ãæ·ÖÎö»ùÒòµÄ¹¦ÄÜ£¬Ê¹µÃÉúÎïѧÑо¿´Ó¶Ôµ¥Ò»»ùÒò»òµ°°×ÖʵÃÑо¿×ªÏò¶à¸ö»ùÒò»òµ°°×ÖÊͬʱ½øÐÐϵͳµÄÑо¿¡£ Smo'&x
-b<+Ra
RNAi ºÍ·´ÒåRNA =>Efrma
RNA¸ÉÈÅ(RNA interference£¬RNAi)ÊÇÓÉË«Á´RNA(double-strandedRNA£¬dsRNA)Òý·¢µÄת¼ºó»ùÒò¾²Ä¬»úÖÆ¡£ RNAiµÄ»úÖÆ¿ÉÄÜÊÇË«Á´RNA½øÈëϸ°ûºó£¬ÔÚDicerøµÄ×÷ÓÃÏ£¬±»Çиî³É21-23 bp´óСµÄС·Ö×Ó¸ÉÈÅRNAƬ¶Î(small interfering RNAs£¬siRNAs)£¬siRNAs½áºÏÒ»¸öºËø¸´ºÏÎï´Ó¶øÐγÉËùνRNAÓÕµ¼³ÁĬ¸´ºÏÎRNA-induced silencing complex, RISC£©¡£¼¤»îµÄRISC¿ÉÒÔ¾«È·½µ½âÓësiRNAsÐòÁÐÏàͬµÄmRNA£¬ÍêÈ«ÒÖÖÆÁ˸ûùÒòÔÚϸ°ûÄڵķÒëºÍ±í´ï¡£ÉúÎïÌåÄÚµÄË«Á´RNA¿ÉÀ´×ÔÓÚRNA²¡¶¾¸ÐȾ£¬×ª×ù×ÓµÄת¼²úÎÍâÔ´µ¼ÈëµÄ»ùÒò¡£ÕâЩÀ´Ô´µÄË«Á´RNAÓÕ·¢ÁËϸ°ûÄÚµÄRNAi»úÖÆ£¬½á¹ûÊDz¡¶¾±»Çå³ý£¬×ª×ù×ӵıí´ï±»×è¶Ï£¬ÍâÔ´µ¼Èë»ùÒò±í´ï±»×è¶Ïͬʱ£¬ÓëÆäͬԴµÄϸ°û»ùÒò×éÖеĻùÒò±í´ïÒ²±»×è¶Ï¡£ W&nVVV8s@
ÓÉÓÚÉÙÁ¿µÄË«Á´RNA¾ÍÄÜ×è¶Ï»ùÒòµÄ±í´ï£¬²¢ÇÒÕâÖÖЧӦ¿ÉÒÔ´«µÝµ½×Ó´úϸ°ûÖУ¬Ñо¿ÕßÃÇÍÆ²âϸ°ûÄÚ´æÔÚRNAiЧӦµÄÀ©Ôöϵͳ¡£Ñо¿ÕßÃÇ·¢ÏÖ£¬ÔÚÕæºËϸ°ûÖÐÒ²´æÔÚÄÜÒÔRNAΪģ°åÖ¸µ¼RNAºÏ³ÉµÄ¾ÛºÏø£¨RNA-directed RNA polymerase£¬RdRP£©¡£ÔÚRdRPµÄ×÷ÓÃÏ£¬½øÈëϸ°ûÄÚµÄË«Á´RNAͨ¹ýÀàËÆÓÚPCRµÄ·´Ó¦¹ý³Ì£¬³ÊÖ¸Êý¼¶µÄÊýÁ¿À©Ôö¡£ g|Cnj
Ë«Á´RNA½øÈëϸ°ûºó£¬Ò»·½ÃæÔÚDicerøµÄ×÷ÓÃϱ»Áѽâ³ÉsiRNA£¬ÁíÒ»·½ÃæÔÚRdRPµÄ×÷ÓÃÏÂ×ÔÉíÀ©Ôöºó£¬ÔÙ±»DicerøÁѽâ³ÉsiRNA¡£SiRNAµÄË«Á´½â¿ª±ä³Éµ¥Á´£¬²¢ºÍijЩµ°°×Ðγɸ´ºÏÎ´Ë¸´ºÏÎïͬÓësiRNA»¥²¹µÄmRNA½áºÏ£¬Ò»·½ÃæÊ¹mRNA±»RNAøÁѽ⣬ÁíÒ»·½ÃæÒÔSiRNA×÷ΪÒýÎÒÔmRNAΪģ°å£¬ÔÚRdRP×÷ÓÃϺϳɳömRNAµÄ»¥²¹Á´¡£½á¹ûmRNAÒ²±ä³ÉÁËË«Á´RNA£¬ËüÔÚDicerøµÄ×÷ÓÃÏÂÒ²±»Áѽâ³ÉsiRNA¡£ÕâЩÐÂÉú³ÉµÄsiRNAÒ²¾ßÓÐÓÕ·¢RNAiµÄ×÷Óã¬Í¨¹ýÕâ¸ö¾ÛºÏøÁ´Ê½·´Ó¦£¬Ï¸°ûÄÚµÄsiRNA´ó´óÔö¼Ó£¬ÏÔÖøÔö¼ÓÁ˶ԻùÒò±í´ïµÄÒÖÖÆ¡£´Ó21µ½23¸öºËÜÕËáµÄsiRNAµ½¼¸°Ù¸öºËÜÕËáµÄË«Á´RNA¶¼ÄÜÓÕ·¢RNAi£¬µ«³¤µÄË«Á´RNA×è¶Ï»ùÒò±í´ïµÄЧ¹ûÃ÷ÏÔÇ¿Óڶ̵ÄË«Á´RNA¡£ b?l\QMvi
·´ÒåRNA (antisense RNA) ÊÇÒ»ÖÖ±¾Éíȱ·¦±àÂëÄÜÁ¦,µ«ÄÜÓëÌØÒì°ÐRNA(Ö÷ÒªÊÇmRNA) »¥²¹µÄRNA ·Ö×Ó,Ëü¿Éͨ¹ýÅä¶Ô¼î»ù¼äÇâ¼ü×÷ÓÃÓë°ÐRNA µÄÌØ¶¨»¥²¹ÇøÓò½áºÏÐγÉË«Á´¸´ºÏÎï,ÒÖÖÆ°ÐRNA µÄ¹¦ÄÜ,´Ó¶øµ÷¿Ø»ùÒòµÄÕý³£±í´ï¡£·´ÒåRNA ¼¼ÊõµÄ»ù±¾ÔÀíÊÇÀûÓÃ×ÔÈ»´æÔڵĻòÈ˹¤ºÏ³ÉµÄ·´ÒåRNA,ͨ¹ý»ùÒòÖØ×é¼¼Êõ·´Ïò²åÈëµ½ºÏÊʵıí´ïÔØÌåÐγÉÖØ×éDNA ,È»ºóתȾÊÜÌåϸ°û,ÔòÕâÒ»·´Ïò²åÈëµÄÐòÁоͻáËæÏ¸°ûÖÜÆÚ²úÉú´óÁ¿·´ÒåRNA ,¶Ô»ùÒòµÄ±í´ï½øÐе÷¿Ø,´Ó¶øÒÖÖÆ¡¢·â±Õ»òÆÆ»µ°Ð»ùÒòµÄ±í´ï¡£Ñ¡Ôñ¾ßÓÐÃ÷ÏÔµÄÉúÎïѧЧӦµÄ°ÐÐòÁкó,·´ÒåRNA ¼´Í¨¹ýºÍÏàÓ¦µÄRNA »¥²¹¶ø´ïµ½×è¶ÏÆä¹¦ÄܵÄÄ¿µÄ¡£ GbhaibkO
+=QboU
N
YAC£¨yeast artificial chromosome£¬YAC£© @,hvXl-G *
Ò»ÖÖÄܹ»¿Ë¡³¤´ï400KbµÄDNAƬ¶ÎµÄÔØÌ壬º¬ÓнÍĸϸ°ûÖбØÐèµÄ¶ËÁ£¡¢×ÅË¿µãºÍ¸´ÖÆÆðʼÐòÁС£ ;%&@^;@k%
BAC (Bacterial Artifical Chromosome£¬BAC) 8w4.|h5FP
BACϵͳÊÇ»ùÓڴ󳦸˾úÖпɴóÈÝÁ¿ÈÝÄÉ»ùÒòÇÒÎȶ¨ÐÔÁ¼ºÃµÄFÒò×ÓÑÜÉú¶øÀ´µÄÔØÌåϵͳ£¬¿ÉÈÝÄɳ¬¹ý100kbµÄ²åÈëÆ¬¶Î£¬BAC¿Ë¡µÄ²åÈëÆ¬¶ÎµÄƽ¾ù³¤¶ÈΪ120kb£¬×î´ó¿É´ïµ½240kb×óÓÒ¡£Á¼ºÃµÄÎȶ¨ÐԺͲÙ×÷µÄ¼ò±ãÐÔÊÇBACϵͳµÄÖ÷ÒªÓŵ㡣 )!Bv8&;e
!q?}[E2
PAC£¨P1 bacteriophage artificial cromosome£¬PAC£© ;iWCV&>w
PACϵͳÊÇÒÔÊɾúÌåP1Ϊ»ù´¡µÄ¿Ë¡ϵͳ£¬Ëü¿ÉÈÝÄÉ70¡«100kbµÄ²åÈëÆ¬¶Î£¬²¢¿ÉÑ¡ÔñÐÔµØÇø·ÖÖØ×é×ӺͷÇÖØ×é×Ó£¬ÇÒͬʱÓÐÁ½Ì׸´ÖÆ»úÖÆ¡£µ¥¿½±´¸´ÖÆ×Ó¿ÉÓÃÓÚÎȶ¨¿Ë¡ÔöÖ³£¬¶ø¶à¿½±´¸´ÖÆ×ÓÔò¿ÉÔÚLac²Ù×Ý×ӵĿØÖÆÏÂÓÃÓÚDNAµÄÖÆ±¸¡£ *Co+UJjT
6mZFsB
CAP ·Ö½â´úл»î»¯µ°°×£¬ÊÇÔºËE. coliϸ°ûÄÚ×÷ÓÃ×îÇ¿µÄ»ùÒòµ÷½ÚÎïÖ®Ò»£¬ÊÇ¿ØÖÆÓªÑø´úлÓйصÄÒ»ÌײÙ×Ý×ӵļ¤»îµ°°×¡£CAPͨ¹ý½áºÏcAMP¶øÐγɻµÄCAP£cAMP¸´ºÏÎÄܽáºÏµ½²Ù×Ý×ӵįô¶¯×ÓÉÏ»ò¸½½üµÄÌØÒìCAP½áºÏλµã£¬°ïÖúRNA¾ÛºÏøÓÐЧµÄ½áºÏµ½Æô¶¯×ÓÉÏ£¬Ìá¸ßÐγɷâ±ÕÆðʼ¸´ºÏÎïµÄËÙ¶È£¬´Ó¶øÌá¸ßÁËת¼ЧÂÊ¡£CAPµÄ×÷ÓÃλµãÔÚËüµ÷¿ØµÄ¸÷ÖÖ²Ù×Ý×ÓÖж¼´¦ÓÚÀ뿪ת¼Æðʼλµã²»Í¬µÄ¾àÀë¡£ 5E]I
<